申请人:BioChem Pharma Inc.
公开号:US20020137947A1
公开(公告)日:2002-09-26
A novel compound which inhibits certain integrins, particularly &agr;
v
integrins. Additionally, the novel compound may be used in a method of treating tumors or cancer which comprises administering a pharmaceutically effective amount of the compound to a patient. Additionally, the novel compound may be used in a method of inhibiting angiogensis. Finally, a method of producing the novel compound is disclosed.
一种新的化合物,可以抑制某些整合素,特别是αv整合素。此外,这种新化合物可用于治疗肿瘤或癌症的方法,包括向患者施用化合物的药效有效量。此外,这种新化合物可用于抑制血管生成的方法。最后,还披露了一种生产这种新化合物的方法。